Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco, Edwards, and UPS and Encourages Investors to Contact the Firm
- Class action lawsuits filed against Elanco Animal Health, Edwards Lifesciences, and UPS were announced by Bragar Eagel & Squire, P.C. on October 21, 2024.
- The lawsuits are based on claims that these companies made materially false statements regarding their business operations and financial forecasts during specified class periods, which negatively impacted shareholders.
- Investors are encouraged to join these class actions to seek restitution for their losses caused by the alleged misleading information.
On October 21, 2024, Bragar Eagel & Squire, P.C., a law firm known for its focus on shareholder rights, announced that class action lawsuits have been filed against Elanco Animal Health Incorporated, Edwards Lifesciences Corp, and United Parcel Service, Inc. These lawsuits are based on allegations of misleading statements made by the companies regarding their business operations and financial prospects during specific class periods. For Elanco, the class period spans from November 7, 2023, to June 26, 2024, with the lead plaintiff deadline on December 6, 2024. Investors claim that Elanco misrepresented the safety of its product Zenrelia and its ability to meet approval timelines, ultimately impacting shareholder confidence. In the case of Edwards Lifesciences, the class period runs from February 6, 2024, to July 24, 2024, with a lead plaintiff deadline of December 13, 2024. The complaint highlights the company's failure to disclose problems related to the growth of its core product, TAVR. Following this disclosure, Edwards' stock price plummeted by about 31% the day after their revelations, indicating a significant loss in investor value. Finally, the lawsuit concerning UPS covers the period of January 30, 2024, to July 22, 2024, with a lead plaintiff deadline of December 9, 2024. Allegations against UPS include misleading investors about expected revenue and their capacity to manage spikes in volume. The firm encourages affected investors to participate in these lawsuits to seek potential recoveries for their losses.